PATRICK G ENRIGHT Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PATRICK G ENRIGHT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PATRICK G ENRIGHT. PATRICK G ENRIGHT is Director in Urigen Pharmaceuticals, Inc. ($VLTS) and Director in CORCEPT THERAPEUTICS INC ($CORT) and Director in Jazz Pharmaceuticals plc ($JAZZ) and Director in Esperion Therapeutics, Inc. ($ESPR) and Director in Aimmune Therapeutics, Inc. ($AIMT) and in Aptinyx Inc. ($APTX) and Director in Aptinyx Inc. ($APTX) and Director in Vera Therapeutics, Inc. ($VERA).
Latest Insider Trading Transactions of PATRICK G ENRIGHT
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIMT, APTX, CORT, ESPR, JAZZ, VLTS, VERA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 18 2021 | VERA | Vera Therapeutics, ... | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 2,187,504 | 0 | 0 | |
May 18 2021 | VERA | Vera Therapeutics, ... | ENRIGHT PATRICK G | Director | Buy | P | 11.00 | 909,090 | 9,999,990 | 3,096,594 | 2.2 M to 3.1 M (+41.56 %) |
May 18 2021 | VERA | Vera Therapeutics, ... | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 2,187,504 | 0 | 2,187,504 | 0 to 2.2 M |
Nov 13 2020 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 147.61 | 1,623 | 239,575 | 20,368 | 22 K to 20.4 K (-7.38 %) |
Nov 13 2020 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 147.00 | 5,083 | 747,217 | 21,991 | 27.1 K to 22 K (-18.77 %) |
Nov 13 2020 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 145.81 | 3,223 | 469,946 | 27,074 | 30.3 K to 27.1 K (-10.64 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 17.11 | 15,398 | 263,460 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 19.90 | 11,432 | 227,497 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 32.79 | 7,500 | 245,925 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 18.26 | 17,500 | 319,550 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 15.40 | 19,755 | 304,227 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 6.29 | 52,421 | 329,728 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 0.14 | 65,849 | 9,219 | 0 | |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | D | 34.50 | 7,840 | 270,480 | 0 | 7.8 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | U | 34.50 | 91,697 | 3,163,547 | 0 | 91.7 K to 0 (-100.00 %) |
Oct 14 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | U | 34.50 | 70,561 | 2,434,355 | 0 | 70.6 K to 0 (-100.00 %) |
Oct 02 2020 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Option Exercise | A | 3.38 | 8,379 | 28,321 | 8,379 | ||
Sep 23 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | J | 0.00 | 91,697 | 0 | 91,697 | 0 to 91.7 K |
Sep 23 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | J | 0.00 | 6,113,134 | 0 | 0 | 6.1 M to 0 (-100.00 %) |
Sep 23 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | J | 0.00 | 91,697 | 0 | 91,697 | 0 to 91.7 K |
Sep 23 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | J | 0.00 | 6,113,134 | 0 | 0 | 6.1 M to 0 (-100.00 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 2,705 | 0 | 20,368 | 17.7 K to 20.4 K (+15.31 %) |
May 29 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 17.11 | 15,398 | 263,460 | 15,398 | |
May 29 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | S | 0.00 | 7,840 | 0 | 78,401 | 70.6 K to 78.4 K (+11.11 %) |
Apr 02 2020 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Option Exercise | A | 2.16 | 8,573 | 18,518 | 8,573 | |
Mar 19 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 11.06 | 16,213 | 179,345 | 70,561 | 54.3 K to 70.6 K (+29.83 %) |
Mar 19 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 11.50 | 8,787 | 101,051 | 54,348 | 45.6 K to 54.3 K (+19.29 %) |
Mar 19 2020 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 11.40 | 100,000 | 1,139,650 | 6,113,134 | 6 M to 6.1 M (+1.66 %) |
Jan 14 2020 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Buy | P | 3.00 | 166,667 | 500,001 | 3,356,746 | 3.2 M to 3.4 M (+5.22 %) |
Jan 14 2020 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Buy | P | 3.00 | 95,000 | 285,000 | 95,000 | 0 to 95 K |
Jan 03 2020 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Option Exercise | A | 3.42 | 5,427 | 18,560 | 5,427 | |
Oct 02 2019 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Option Exercise | A | 3.49 | 5,582 | 19,481 | 5,582 | |
Oct 02 2019 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Option Exercise | A | 3.49 | 5,582 | 19,481 | 5,582 | |
Sep 19 2019 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Grant | A | 22.34 | 12,500 | 279,216 | 45,561 | 33.1 K to 45.6 K (+37.81 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 135.65 | 726 | 98,481 | 17,663 | 18.4 K to 17.7 K (-3.95 %) |
Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 1,920 | 0 | 18,389 | 16.5 K to 18.4 K (+11.66 %) |
May 28 2019 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 19.90 | 11,432 | 227,497 | 11,432 | |
May 28 2019 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 6,442 | 0 | 33,061 | 26.6 K to 33.1 K (+24.20 %) |
May 17 2019 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Option Exercise | A | 3.73 | 40,000 | 149,200 | 40,000 | |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | M | 143.66 | 3,415 | 490,599 | 0 | |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | M | 138.08 | 3,415 | 471,543 | 0 | |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | M | 135.44 | 3,300 | 446,952 | 0 | |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 169.69 | 1,000 | 169,694 | 16,469 | 17.5 K to 16.5 K (-5.72 %) |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 168.86 | 7,086 | 1,196,565 | 17,469 | 24.6 K to 17.5 K (-28.86 %) |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 167.96 | 2,044 | 343,305 | 24,555 | 26.6 K to 24.6 K (-7.68 %) |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | M | 135.44 | 3,300 | 446,952 | 26,599 | 23.3 K to 26.6 K (+14.16 %) |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | M | 138.08 | 3,415 | 471,543 | 23,299 | 19.9 K to 23.3 K (+17.17 %) |
Sep 07 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | M | 143.66 | 3,415 | 490,599 | 19,884 | 16.5 K to 19.9 K (+20.74 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 175.13 | 1,365 | 239,057 | 16,469 | 17.8 K to 16.5 K (-7.65 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 1,495 | 0 | 17,834 | 16.3 K to 17.8 K (+9.15 %) |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 21,946,301 | 0 | 0 | |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 21,946,301 | 0 | 0 | |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 33,022,786 | 0 | 0 | |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 33,022,786 | 0 | 0 | |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 28,895,188 | 0 | 0 | |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Option Exercise | C | 0.00 | 28,895,188 | 0 | 0 | |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Buy | P | 16.00 | 150,000 | 2,400,000 | 3,190,079 | 3 M to 3.2 M (+4.93 %) |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Buy | P | 16.00 | 150,000 | 2,400,000 | 3,190,079 | 3 M to 3.2 M (+4.93 %) |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 795,553 | 0 | 3,040,079 | 2.2 M to 3 M (+35.44 %) |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 795,553 | 0 | 3,040,079 | 2.2 M to 3 M (+35.44 %) |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 1,197,076 | 0 | 2,244,526 | 1 M to 2.2 M (+114.28 %) |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 1,197,076 | 0 | 2,244,526 | 1 M to 2.2 M (+114.28 %) |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 1,047,450 | 0 | 1,047,450 | 0 to 1 M |
Jun 26 2018 | APTX | Aptinyx Inc. | ENRIGHT PATRICK G | Director | Buy | C | 0.00 | 1,047,450 | 0 | 1,047,450 | 0 to 1 M |
May 24 2018 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 32.79 | 7,500 | 245,925 | 7,500 | |
May 24 2018 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 3,750 | 0 | 26,619 | 22.9 K to 26.6 K (+16.40 %) |
Feb 26 2018 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 32.00 | 15,593 | 498,976 | 22,869 | 7.3 K to 22.9 K (+214.31 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | M | 81.76 | 4,500 | 367,920 | 0 | |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | M | 46.83 | 4,500 | 210,735 | 0 | |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 140.50 | 2,842 | 399,294 | 16,339 | 19.2 K to 16.3 K (-14.82 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 139.56 | 5,358 | 747,771 | 19,181 | 24.5 K to 19.2 K (-21.83 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 138.15 | 800 | 110,516 | 24,539 | 25.3 K to 24.5 K (-3.16 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | M | 81.76 | 4,500 | 367,920 | 25,339 | 20.8 K to 25.3 K (+21.59 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | M | 46.83 | 4,500 | 210,735 | 20,839 | 16.3 K to 20.8 K (+27.54 %) |
Nov 21 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 133.19 | 352 | 46,883 | 1,365 | 1.7 K to 1.4 K (-20.50 %) |
Aug 28 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 148.40 | 351 | 52,088 | 1,717 | 2.1 K to 1.7 K (-16.97 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 144.13 | 3 | 432 | 2,068 | 2.1 K to 2.1 K (-0.14 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 142.36 | 659 | 93,815 | 2,071 | 2.7 K to 2.1 K (-24.14 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 1,365 | 0 | 2,730 | 1.4 K to 2.7 K (+100.00 %) |
May 30 2017 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 18.26 | 17,500 | 319,550 | 17,500 | |
Mar 20 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.94 | 5,305 | 52,722 | 114,675 | 120 K to 114.7 K (-4.42 %) |
Mar 20 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.94 | 264,650 | 2,630,515 | 5,721,372 | 6 M to 5.7 M (-4.42 %) |
Mar 15 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 10.24 | 5,483 | 56,131 | 139,630 | 145.1 K to 139.6 K (-3.78 %) |
Mar 15 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 10.24 | 273,537 | 2,800,636 | 6,966,372 | 7.2 M to 7 M (-3.78 %) |
Mar 15 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 10.01 | 5,895 | 59,002 | 145,113 | 151 K to 145.1 K (-3.90 %) |
Mar 15 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 10.01 | 294,105 | 2,943,668 | 7,239,909 | 7.5 M to 7.2 M (-3.90 %) |
Mar 15 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 11.13 | 412 | 4,585 | 151,008 | 151.4 K to 151 K (-0.27 %) |
Mar 15 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 11.13 | 20,568 | 228,905 | 7,534,014 | 7.6 M to 7.5 M (-0.27 %) |
Mar 10 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.75 | 14,737 | 143,686 | 151,420 | 166.2 K to 151.4 K (-8.87 %) |
Mar 10 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.75 | 735,263 | 7,168,814 | 7,554,582 | 8.3 M to 7.6 M (-8.87 %) |
Feb 27 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.05 | 19,650 | 177,833 | 166,157 | 185.8 K to 166.2 K (-10.58 %) |
Feb 27 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.05 | 980,350 | 8,872,168 | 8,289,845 | 9.3 M to 8.3 M (-10.58 %) |
Feb 27 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 8.65 | 29,475 | 254,959 | 185,807 | 215.3 K to 185.8 K (-13.69 %) |
Feb 27 2017 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 8.65 | 1,470,525 | 12,720,041 | 9,270,195 | 10.7 M to 9.3 M (-13.69 %) |
Dec 14 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Buy | J | 0.00 | 204,210 | 0 | 204,210 | 0 to 204.2 K |
Dec 06 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 101.80 | 677 | 68,919 | 1,365 | 2 K to 1.4 K (-33.15 %) |
Dec 01 2016 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | J | 0.00 | 7,276 | 0 | 7,276 | 0 to 7.3 K |
Dec 01 2016 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Sell | J | 0.00 | 1,500,000 | 0 | 6,013,134 | 7.5 M to 6 M (-19.97 %) |
Nov 30 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | J | 0.00 | 58,950 | 0 | 121,153 | 180.1 K to 121.2 K (-32.73 %) |
Nov 30 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | J | 0.00 | 2,941,050 | 0 | 10,834,849 | 13.8 M to 10.8 M (-21.35 %) |
Nov 25 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.39 | 290 | 2,722 | 180,103 | 180.4 K to 180.1 K (-0.16 %) |
Nov 25 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.39 | 14,451 | 135,650 | 13,775,899 | 13.8 M to 13.8 M (-0.10 %) |
Nov 25 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.30 | 248 | 2,307 | 180,393 | 180.6 K to 180.4 K (-0.14 %) |
Nov 25 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.30 | 12,352 | 114,921 | 13,790,350 | 13.8 M to 13.8 M (-0.09 %) |
Nov 25 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.33 | 189 | 1,763 | 180,641 | 180.8 K to 180.6 K (-0.10 %) |
Nov 25 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.33 | 9,411 | 87,802 | 13,802,702 | 13.8 M to 13.8 M (-0.07 %) |
Nov 21 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.39 | 2,327 | 21,841 | 180,830 | 183.2 K to 180.8 K (-1.27 %) |
Nov 21 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.39 | 116,058 | 1,089,320 | 13,812,113 | 13.9 M to 13.8 M (-0.83 %) |
Nov 21 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.47 | 1,976 | 18,720 | 183,157 | 185.1 K to 183.2 K (-1.07 %) |
Nov 21 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.47 | 98,586 | 933,964 | 13,928,171 | 14 M to 13.9 M (-0.70 %) |
Nov 21 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.64 | 6,389 | 61,612 | 185,133 | 191.5 K to 185.1 K (-3.34 %) |
Nov 21 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.64 | 318,764 | 3,073,969 | 14,026,757 | 14.3 M to 14 M (-2.22 %) |
Nov 17 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.51 | 342 | 3,252 | 191,522 | 191.9 K to 191.5 K (-0.18 %) |
Nov 17 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.51 | 17,052 | 162,142 | 14,345,521 | 14.4 M to 14.3 M (-0.12 %) |
Nov 17 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.55 | 3,094 | 29,558 | 191,864 | 195 K to 191.9 K (-1.59 %) |
Nov 17 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Sell | S | 9.55 | 154,359 | 1,474,653 | 14,362,573 | 14.5 M to 14.4 M (-1.06 %) |
Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 136.45 | 633 | 86,373 | 2,042 | 2.7 K to 2 K (-23.66 %) |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 1,365 | 0 | 2,675 | 1.3 K to 2.7 K (+104.20 %) |
Jul 25 2016 | CORT | CORCEPT THERAPEUTI ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 5.86 | 30,000 | 175,800 | 30,000 | |
May 27 2016 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 15.40 | 19,755 | 304,227 | 19,755 | |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 120.31 | 7 | 842 | 4,323 | 4.3 K to 4.3 K (-0.16 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 119.55 | 34 | 4,065 | 4,330 | 4.4 K to 4.3 K (-0.78 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 118.39 | 63 | 7,459 | 4,364 | 4.4 K to 4.4 K (-1.42 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 117.46 | 52 | 6,108 | 4,427 | 4.5 K to 4.4 K (-1.16 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 116.19 | 34 | 3,951 | 4,479 | 4.5 K to 4.5 K (-0.75 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 114.43 | 6 | 687 | 4,513 | 4.5 K to 4.5 K (-0.13 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 120.33 | 393 | 47,288 | 215,677 | 216.1 K to 215.7 K (-0.18 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 119.55 | 1,666 | 199,165 | 216,070 | 217.7 K to 216.1 K (-0.77 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 118.40 | 3,159 | 374,013 | 217,736 | 220.9 K to 217.7 K (-1.43 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 117.46 | 2,594 | 304,692 | 220,895 | 223.5 K to 220.9 K (-1.16 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 116.20 | 1,698 | 197,304 | 223,489 | 225.2 K to 223.5 K (-0.75 %) |
Feb 12 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 114.43 | 294 | 33,641 | 225,187 | 225.5 K to 225.2 K (-0.13 %) |
Mar 31 2016 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 14.15 | 45,440 | 642,817 | 7,513,134 | 7.5 M to 7.5 M (+0.61 %) |
Mar 31 2016 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 13.50 | 33,064 | 446,318 | 7,467,694 | 7.4 M to 7.5 M (+0.44 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 139.24 | 24 | 3,342 | 4,519 | 4.5 K to 4.5 K (-0.53 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 138.37 | 57 | 7,887 | 4,543 | 4.6 K to 4.5 K (-1.24 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 137.71 | 116 | 15,974 | 4,600 | 4.7 K to 4.6 K (-2.46 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 139.25 | 1,214 | 169,043 | 225,481 | 226.7 K to 225.5 K (-0.54 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 138.37 | 2,843 | 393,371 | 226,695 | 229.5 K to 226.7 K (-1.24 %) |
Jan 07 2016 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 137.71 | 5,746 | 791,274 | 229,538 | 235.3 K to 229.5 K (-2.44 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 148.49 | 424 | 62,960 | 1,310 | 1.7 K to 1.3 K (-24.45 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 147.57 | 34 | 5,018 | 4,716 | 4.8 K to 4.7 K (-0.72 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 146.96 | 68 | 9,993 | 4,750 | 4.8 K to 4.8 K (-1.41 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 145.96 | 94 | 13,720 | 4,818 | 4.9 K to 4.8 K (-1.91 %) |
Dec 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 147.58 | 1,737 | 256,339 | 235,284 | 237 K to 235.3 K (-0.73 %) |